HYBRID EVENT: Join us in person in Boston, Massachusetts, USA or attend virtually from anywhere.
Obesity-related liver diseases

Obesity is a significant risk factor for liver diseases, particularly non-alcoholic fatty liver disease (NAFLD), which is characterized by excess fat accumulation in liver cells. NAFLD can progress to non-alcoholic steatohepatitis (NASH), liver fibrosis, and even cirrhosis if left untreated. The excess fat in obesity promotes inflammation and insulin resistance, further exacerbating liver damage. Weight loss, dietary modifications, and physical activity are critical in managing obesity-related liver conditions. Recognizing and addressing liver health in obesity is vital, as it can prevent severe liver complications and improve overall metabolic health, emphasizing the importance of comprehensive obesity management.

Committee Members
Speaker at World Obesity and Weight Management Congress 2026 - Russell Rising

Russell Rising

D & S Consulting Services Inc, United States
Speaker at World Obesity and Weight Management Congress 2026 - Robert Gabbay

Robert Gabbay

Harvard Medical School, United States
Speaker at World Obesity and Weight Management Congress 2026 - Hassan Massoud Heshmati

Hassan Massoud Heshmati

Endocrinology Metabolism Consulting, LLC, Hassan Heshmati and Valerie Shaw Endocrine Research, United States
WOC 2026 Speakers
Speaker at World Obesity and Weight Management Congress 2026 - Melinda J Watman

Melinda J Watman

President & Founder of Weighty Decision, United States
Speaker at World Obesity and Weight Management Congress 2026 - Michelle Petties

Michelle Petties

Brand New Now Press, United States
Speaker at World Obesity and Weight Management Congress 2026 - Kelly Broadwater

Kelly Broadwater

Chrysalis Center for Counseling and Eating Disorder Treatment, United States
Speaker at World Obesity and Weight Management Congress 2026 - Jesse Cochrane

Jesse Cochrane

Lipedema Foundation, United States
Tags

Submit your abstract Today

Twitter XTwitter
Watsapp